Laminar flow attenuates interferon-induced inflammatory responses in endothelial cells

Cardiovascular Research

Volumn 74, Issue 3, 2007, Pages 497-505

  Tsai, Yu Chih ^a   Hsieh, Hsyue Jen ^b   Liao, Fang ^a   Ni, Chih Wen ^a   Chao, Yuen Jen ^a   Hsieh, Chung Yu ^b   Wang, Danny Ling ^a  

^a INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

CXC chemokines; Endothelial cells; Interferon gamma; Laminar flow; STAT1

Indexed keywords

ALPHA CHEMOKINE; CIITA PROTEIN; CXCL11 CHEMOKINE; CXCL9 CHEMOKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GENE PRODUCT; INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; SERINE; STAT1 PROTEIN; TYROSINE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATION; LAMINAR FLOW; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SHEAR FLOW; T LYMPHOCYTE; TRANSCRIPTION REGULATION; UMBILICAL CORD;

ATHEROSCLEROSIS; BLOTTING, WESTERN; CELL MOVEMENT; CELLS, CULTURED; CHEMOKINES, CXC; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ENDOTHELIAL CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; INTERFERON-GAMMA, RECOMBINANT; NUCLEAR PROTEINS; PHOSPHORYLATION; REGIONAL BLOOD FLOW; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; STAT1 TRANSCRIPTION FACTOR; STRESS, MECHANICAL; TIME FACTORS; TRANS-ACTIVATORS;

EID: 34247892467     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardiores.2007.02.030     Document Type: Article

References (43)

1. Davies P.F., Remuzzi A., Gordon E.J., Dewey Jr. C.F., and Gimbrone Jr. M.A. Turbulent fluid shear stress induces vascular endothelial cell turnover in vitro. Proc Natl Acad Sci U S A 83 (1986) 2114-2117
2. Lin K., Hsu P.P., Chen B.P., Yuan S., Usami S., Shyy J.Y., et al. Molecular mechanism of endothelial growth arrest by laminar shear stress. Proc Natl Acad Sci U S A 97 (2000) 9385-9389
3. Malek A.M., Alper S.L., and Izumo S. Hemodynamic shear stress and its role in atherosclerosis. Jama 282 (1999) 2035-2042
4. Zarins C.K., Giddens D.P., Bharadvaj B.K., Sottiurai V.S., Mabon R.F., and Glagov S. Carotid bifurcation atherosclerosis. Quantitative correlation of plaque localization with flow velocity profiles and wall shear stress. Circ Res 53 (1983) 502-514
5. Asakura T., and Karino T. Flow patterns and spatial distribution of atherosclerotic lesions in human coronary arteries. Circ Res 66 (1990) 1045-1066
6. Noris M., Morigi M., Donadelli R., Aiello S., Foppolo M., Todeschini M., et al. Nitric oxide synthesis by cultured endothelial cells is modulated by flow conditions. Circ Res 76 (1995) 536-543
7. Topper J.N., Cai J., Falb D., and Gimbrone Jr. M.A. Identification of vascular endothelial genes differentially responsive to fluid mechanical stimuli: cyclooxygenase-2, manganese superoxide dismutase, and endothelial cell nitric oxide synthase are selectively up-regulated by steady laminar shear stress. Proc Natl Acad Sci U S A 93 (1996) 10417-10422
8. Chen X.L., Varner S.E., Rao A.S., Grey J.Y., Thomas S., Cook C.K., et al. Laminar flow induction of antioxidant response element-mediated genes in endothelial cells. A novel anti-inflammatory mechanism. J Biol Chem 278 (2003) 703-711
9. Yamawaki H., Pan S., Lee R.T., and Berk B.C. Fluid shear stress inhibits vascular inflammation by decreasing thioredoxin-interacting protein in endothelial cells. J Clin Invest 115 (2005) 733-738
10. Liu Y., Yin G., Surapisitchat J., Berk B.C., and Min W. Laminar flow inhibits TNF-induced ASK1 activation by preventing dissociation of ASK1 from its inhibitor 14-3-3. J Clin Invest 107 (2001) 917-923
11. Hojo Y., Saito Y., Tanimoto T., Hoefen R.J., Baines C.P., Yamamoto K., et al. Fluid shear stress attenuates hydrogen peroxide-induced c-Jun NH2-terminal kinase activation via a glutathione reductase-mediated mechanism. Circ Res 91 (2002) 712-718
12. Ni C.W., Hsieh H.J., Chao Y.J., and Wang D.L. Shear flow attenuates serum-induced STAT3 activation in endothelial cells. J Biol Chem 278 (2003) 19702-19708
13. Ni C.W., Hsieh H.J., Chao Y.J., and Wang D.L. Interleukin-6-induced JAK2/STAT3 signaling pathway in endothelial cells is suppressed by hemodynamic flow. Am J Physiol Cell Physiol 287 (2004) C771-C780
14. Madej A., Okopien B., Kowalski J., Zielinski M., Wysocki J., Szygula B., et al. Effects of fenofibrate on plasma cytokine concentrations in patients with atherosclerosis and hyperlipoproteinemia IIb. Int J Clin Pharmacol Ther 36 (1998) 345-349
15. Juvonen J., Surcel H.M., Satta J., Teppo A.M., Bloigu A., Syrjala H., et al. Elevated circulating levels of inflammatory cytokines in patients with abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol 17 (1997) 2843-2847
16. Mach F., Sauty A., Iarossi A.S., Sukhova G.K., Neote K., Libby P., et al. Differential expression of three T lymphocyte-activating CXC chemokines by human atheroma-associated cells. J Clin Invest 104 (1999) 1041-1050
17. Liuzzo G., Vallejo A.N., Kopecky S.L., Frye R.L., Holmes D.R., Goronzy J.J., et al. Molecular fingerprint of interferon-gamma signaling in unstable angina. Circulation 103 (2001) 1509-1514
18. Stokes K.Y., Clanton E.C., Clements K.P., and Granger D.N. Role of interferon-gamma in hypercholesterolemia-induced leukocyte-endothelial cell adhesion. Circulation 107 (2003) 2140-2145
19. Gupta S., Pablo A.M., Jiang X., Wang N., Tall A.R., and Schindler C. IFN-gamma potentiates atherosclerosis in ApoE knock-out mice. J Clin Invest 99 (1997) 2752-2761
20. Aaronson D.S., and Horvath C.M. A road map for those who don't know JAK-STAT. Science 296 (2002) 1653-1655
21. Sana T.R., Janatpour M.J., Sathe M., McEvoy L.M., and McClanahan T.K. Microarray analysis of primary endothelial cells challenged with different inflammatory and immune cytokines. Cytokine 29 (2005) 256-269
22. Laich A., Meyer M., Werner E.R., and Werner-Felmayer G. Structure and expression of the human small cytokine B subfamily member 11 (SCYB11/formerly SCYB9B, alias I-TAC) gene cloned from IFN-gamma-treated human monocytes (THP-1). J Interferon Cytokine Res 19 (1999) 505-513
23. Stemme S., Holm J., and Hansson G.K. T lymphocytes in human atherosclerotic plaques are memory cells expressing CD45RO and the integrin VLA-1. Arterioscler Thromb 12 (1992) 206-211
24. Pober J.S., Collins T., Gimbrone Jr. M.A., Cotran R.S., Gitlin J.D., Fiers W., et al. Lymphocytes recognize human vascular endothelial and dermal fibroblast Ia antigens induced by recombinant immune interferon. Nature 305 (1983) 726-729
25. Pober J.S., Collins T., Gimbrone Jr. M.A., Libby P., and Reiss C.S. Inducible expression of class II major histocompatibility complex antigens and the immunogenicity of vascular endothelium. Transplantation 41 (1986) 141-146
26. Labarrere C.A., Nelson D.R., and Faulk W.P. Endothelial activation and development of coronary artery disease in transplanted human hearts. Jama 278 (1997) 1169-1175
27. Chiu J.J., Wung B.S., Hsieh H.J., Lo L.W., and Wang D.L. Nitric oxide regulates shear stress-induced early growth response-1. Expression via the extracellular signal-regulated kinase pathway in endothelial cells. Circ Res 85 (1999) 238-246
28. Hsieh H.J., Cheng C.C., Wu S.T., Chiu J.J., Wung B.S., and Wang D.L. Increase of reactive oxygen species (ROS) in endothelial cells by shear flow and involvement of ROS in shear-induced c-fos expression. J Cell Physiol 175 (1998) 156-162
29. Wang Y., Chang J., Li Y.C., Li Y.S., Shyy J.Y., and Chien S. Shear stress and VEGF activate IKK via the Flk-1/Cbl/Akt signaling pathway. Am J Physiol Heart Circ Physiol 286 (2004) H685-H692
30. Marx N., Mach F., Sauty A., Leung J.H., Sarafi M.N., Ransohoff R.M., et al. Peroxisome proliferator-activated receptor-gamma activators inhibit IFN-gamma-induced expression of the T cell-active CXC chemokines IP-10, Mig, and I-TAC in human endothelial cells. J Immunol 164 (2000) 6503-6508
31. Dunzendorfer S., Lee H.K., and Tobias P.S. Flow-dependent regulation of endothelial Toll-like receptor 2 expression through inhibition of SP1 activity. Circ Res 95 (2004) 684-691
32. Brooks A.R., Lelkes P.I., and Rubanyi G.M. Gene expression profiling of human aortic endothelial cells exposed to disturbed flow and steady laminar flow. Physiol Genomics 9 (2002) 27-41
33. Brooks A.R., Lelkes P.I., and Rubanyi G.M. Gene expression profiling of vascular endothelial cells exposed to fluid mechanical forces: relevance for focal susceptibility to atherosclerosis. Endothelium 11 (2004) 45-57
34. Isaacs A., and Lindenmann J. Virus interference I. The interferon. By A. Isaacs and J. Lindenmann, 1957. J Interf Res 7 (1987) 429-438
35. Whitman S.C., Ravisankar P., and Daugherty A. Interleukin-18 enhances atherosclerosis in apolipoprotein E(-/-) mice through release of interferon-gamma. Circ Res 90 (2002) E34-E38
36. Wen Z., Zhong Z., and Darnell Jr. J.E. Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation. Cell 82 (1995) 241-250
37. Ranjan V., Xiao Z., and Diamond S.L. Constitutive NOS expression in cultured endothelial cells is elevated by fluid shear stress. Am J Physiol 269 (1995) H550-H555
38. Mohan S., Hamuro M., Sorescu G.P., Koyoma K., Sprague E.A., Jo H., et al. IkappaBalpha-dependent regulation of low-shear flow-induced NF-kappa B activity: role of nitric oxide. Am J Physiol Cell Physiol 284 (2003) C1039-C1047
39. Yang Q.W., Mou L., Lv F.L., Wang J.Z., Wang L., Zhou H.J., et al. Role of toll-like receptor 4/NF-kappaB pathway in monocyte-endothelial adhesion induced by low shear stress and ox-LDL. Biorheology 42 (2005) 225-236
40. Llovera M., Pearson J.D., Moreno C., and Riveros-Moreno V. Impaired response to interferon-gamma in activated macrophages due to tyrosine nitration of STAT1 by endogenous nitric oxide. Br J Pharmacol 132 (2001) 419-426
41. Grimm M., Spiecker M., De Caterina R., Shin W.S., and Liao J.K. Inhibition of major histocompatibility complex class II gene transcription by nitric oxide and antioxidants. J Biol Chem 277 (2002) 26460-26467
42. Hansson G.K., Libby P., Schonbeck U., and Yan Z.Q. Innate and adaptive immunity in the pathogenesis of atherosclerosis. Circ Res 91 (2002) 281-291
43. Binder C.J., Chang M.K., Shaw P.X., Miller Y.I., Hartvigsen K., Dewan A., et al. Innate and acquired immunity in atherogenesis. Nat Med 8 (2002) 1218-1226